Gemini Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Muzaarnagar, Uttar Pradesh, India, established in 2005.
2005 Muzaarnagar, Uttar Pradesh, India Active
Last Updated:
Access Report
About Gemini Pharmaceuticals Limited

Gemini Pharmaceuticals Limited, a active public limited company, was established on 02 August 2005 in Muzaarnagar, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24232UP2005PLC030446. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.25 Cr and a paid-up capital of ₹2.20 Cr.

It upholds a active non-compliant status. Its leadership includes Ramdev (Additional Director), Kuwar Singh (Additional Director), Sudhir Kumar (Director). Past directors included Venkat Reddy Kudimuskula, Bharti Garg, Anita Garg. It holds ₹5.27 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 19-A, New Mandi, Muzaarnagar, Uttar Pradesh, 251001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232UP2005PLC030446

  • Registration Number

    030446

  • Incorporation Date

    02 August 2005

  • Authorized Capital

    ₹2.25 Cr

  • Paid-Up Capital

    ₹2.20 Cr

  • ROC Code

    Roc Kanpur

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.25 Cr
  • Paid Up Capital ₹ 2.20 Cr
  • Company Age 20 Year, 6 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 5.27 Cr
  • Revenue Growth **** -9.43%
  • Profit Growth **** 73.92%
  • Ebitda **** 70.42%
  • Net Worth 4.40%
  • Total Assets -8.77%
Company report

Gemini Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Gemini Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Gemini Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Ramdev Additional Director 25 Mar 2023 Current
Kuwar Singh Additional Director 15 Apr 2016 Current
Sudhir Kumar Director 01 Oct 2016 Current
Ajay Kumar Sharma Additional Director 21 Feb 2012 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 26 Aug 2013 Past
Pramod Abcsdd Additional Director 04 Dec 2016 Past
Pramod Abcsdd Additional Director 04 Dec 2016 Past
Pramod Abcsdd Director 30 Mar 2011 Past
Pramod Abcsdd Additional Director 26 Sep 2019 Past
Pramod Abcsdd Additional Director 31 Mar 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Gemini Pharmaceuticals.

Gemini Pharmaceuticals Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 9.43% decrease. The company also saw a substantial improvement in profitability, with a 73.92% increase in profit. The company's net worth moved up by a moderate rise of 4.4%.

Gemini Pharmaceuticals revenue growth over time
Gemini Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -9.43%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -8.77%
*******
*******
*******
*******
Profit or Loss
*******
 73.92%
*******
*******
*******
*******
Net Worth
*******
 4.40%
*******
*******
*******
*******
EBITDA
*******
 70.42%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Gemini Pharmaceuticals?

In 2020, Gemini Pharmaceuticals had a promoter holding of 25.64% and a public holding of 74.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹52,688,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • State Bank Of India : 5.27 Cr
Latest Charge Details
Date Lender Amount Status
04 May 2006 State Bank Of India ₹5.27 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Gemini Pharmaceuticals?

Gemini Pharmaceuticals has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Gemini Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gemini Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Gemini Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Gemini Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    The activity Gemini Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was completed.

  • Director Appointment

    The activity Ramdev was appointed as a Additional Director was appointed as a Additional Director on 25 Mar 2023 & has been associated with this company since 2 years 10 months . was completed.

  • Director Appointment

    The activity Sudhir Kumar was appointed as a Director was appointed as a Director on 01 Oct 2016 & has been associated with this company since 9 years 4 months . was completed.

  • Director Appointment

    Kuwar Singh was appointed as a Additional Director was appointed as a Additional Director on 15 Apr 2016 & has been associated with this company since 9 years 9 months . was recorded as a recent event.

  • Director Appointment

    The activity Ajay Kumar Sharma was appointed as a Additional Director was appointed as a Additional Director on 21 Feb 2012 & has been associated with this company since 13 years 11 months . was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Gemini Pharmaceuticals Limited?

The CIN of Gemini Pharmaceuticals Limited is U24232UP2005PLC030446.

Where is Gemini Pharmaceuticals Limited headquartered?

Gemini Pharmaceuticals Limited is headquartered at 19-A, New Mandi, Muzaarnagar, Uttar Pradesh, 251001.

When was Gemini Pharmaceuticals Limited incorporated?

Gemini Pharmaceuticals Limited was incorporated on 02 August 2005.

Who are the current directors of Gemini Pharmaceuticals Limited?

The current directors of Gemini Pharmaceuticals Limited are

What is the primary industry of Gemini Pharmaceuticals Limited?

The primary industry of Gemini Pharmaceuticals Limited is Pharma.

Is Gemini Pharmaceuticals Limited a listed company?

Gemini Pharmaceuticals Limited is unlisted.

What is the capital structure of Gemini Pharmaceuticals Limited?

The authorized capital of Gemini Pharmaceuticals Limited is ₹2.25 Cr, and the paid-up capital is ₹2.20 Cr.

What is the compliance status of Gemini Pharmaceuticals Limited?

The compliance status of Gemini Pharmaceuticals Limited is Active Non-Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available